Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $755.50
Filed Pursuant to Rule 433 Registration No. 333-165884 June 7, 2010 DARA BioSciences to Present...
RALEIGH, N.C., June 7, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARAD) announced today that Richard A. Franco, R.Ph., Chief...
RALEIGH, N.C., June 1, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARAD) today announced that, on May 28 2010, NASDAQ notified the...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...
RALEIGH, N.C., May 17, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (the "Company") (Nasdaq:DARAD) announced today that it has commenced an...
Table of Contents As filed with the Securities and Exchange Commission on May 17, 2010 Registration...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.